CS Medica AS (STU:8G8) FCF Margin % : -148.55% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CS Medica AS's Free Cash Flow for the three months ended in Sep. 2024 was €-0.77 Mil. CS Medica AS's Revenue for the three months ended in Sep. 2024 was €0.52 Mil. Therefore, CS Medica AS's FCF Margin % for the quarter that ended in Sep. 2024 was -148.55%.

As of today, CS Medica AS's current FCF Yield % is -84.83%.

The historical rank and industry rank for CS Medica AS's FCF Margin % or its related term are showing as below:

STU:8G8' s FCF Margin % Range Over the Past 10 Years
Min: -722.12 Med: -141.78 Max: 6.03
Current: -91.01

During the past 6 years, the highest FCF Margin % of CS Medica AS was 6.03%. The lowest was -722.12%. And the median was -141.78%.

STU:8G8's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -3.62 vs STU:8G8: -91.01

CS Medica AS FCF Margin % Historical Data

The historical data trend for CS Medica AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS FCF Margin % Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

FCF Margin %

Get a 7-Day Free Trial

-50.35

-319.86

-159.28

-722.38

-124.23

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial														-2,360.00	-103.10	18.24	-145.90	-148.55

Competitive Comparison of CS Medica AS's FCF Margin %

For the Medical Devices subindustry, CS Medica AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CS Medica AS's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CS Medica AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CS Medica AS's FCF Margin % falls into.

Save Embed

;

Save Embed

;

CS Medica AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CS Medica AS's FCF Margin for the fiscal year that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2024 )	/	Revenue (A: Sep. 2024 )
	=	-1.41	/	1.135
	=	-124.23 %

CS Medica AS's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-0.771	/	0.519
	=	-148.55 %

CS Medica AS FCF Margin % Related Terms

Thank you for viewing the detailed overview of CS Medica AS's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Indiakaj 10, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines